Cite
HARVARD Citation
Zeng, Y. et al. (2020). Impact of 21-gene recurrence score testing on adjuvant chemotherapy decision making in older patients with breast cancer. Journal of geriatric oncology. 11 (5), pp. 843-849. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zeng, Y. et al. (2020). Impact of 21-gene recurrence score testing on adjuvant chemotherapy decision making in older patients with breast cancer. Journal of geriatric oncology. 11 (5), pp. 843-849. [Online].